Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

Clinical trial NCT06037395 · COMPLETED

Trial details

NCT number: NCT06037395
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subject

Start date: 2021-10-06
Primary completion: 2022-10-20
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.